Similar Search Results

Patents, data exclusivity, and the development of new drugs

Gaessler, Fabian; Wagner, Stefan - 2019

Pharmaceutical firms typically enjoy market exclusivity for new drugs from concurrent protection of the underlying invention (through patents) and the clinical trials data submitted for market approval (through data exclusivity). Patent invalidation during drug development renders data...

Persistent link: https://www.econbiz.de/10012064786

P-hacking in clinical trials and how incentives shape the distribution of results across phases

Adda, Jérôme; Decker, Christian; Ottaviani, Marco - 2019

Persistent link: https://www.econbiz.de/10012179420

The abandoned stakeholders : pharmaceutical companies and research participants

Chang, Pepe Lee - In: Journal of business ethics : JOBE 143 (2017) 4, pp. 721-731

Persistent link: https://www.econbiz.de/10011755398

Co-evolutionary perspective on sourcing portfolios : examining sourcing choices for clinical trials of bio-pharmaceutical firms

Thakur Wernz, Pooja; Bruyaka, Olga - In: Management international review : mir ; journal of … 57 (2017) 6, pp. 909-946

Persistent link: https://www.econbiz.de/10011777755

The risk of innovation : measuring drug clinical development in Brazil

Rocha, Michele de Medeiros; Vieira, Danilo Garbazza; … - In: International journal of business innovation and research 17 (2018) 1, pp. 128-145

Persistent link: https://www.econbiz.de/10011958562

Risk-sharing agreements in pharmaceutical markets

Antoñanzas Villar, Fernando; Juárez-Castelló, Carmelo; … - In: Estudios de economía aplicada : revista promovida por … 31 (2013) 2, pp. 359-378

Persistent link: https://www.econbiz.de/10010207164

Bridging the gap between invention and innovation : Increasing success rates in publicly and industry-funded clinical trials

Häussler, Carolin; Assmus, Anne - In: Research policy : policy, management and economic … 50 (2021) 2, pp. 1-17

Persistent link: https://www.econbiz.de/10012664882

Patents and R&D expenditure effects on equity returns in pharmaceutical industry

Feyzrakhmanova, Martina; Gurdgiev, Constantin - In: Applied economics letters 23 (2016) 4/6, pp. 278-283

Persistent link: https://www.econbiz.de/10011430453

Can prospect theory predict the decision making by professionals? : evidence from the pharmaceutical industry

Yilmaz, Neslihan; Kalaycioglu, Can - In: International journal of applied behavioral economics : … 5 (2016) 1, pp. 24-47

Persistent link: https://www.econbiz.de/10011434801

An integrated model of knowledge acquisition and innovation : examining the mediation effects of knoweldge integration and knowledge application

Dahiyat, Samer E. - In: International journal of learning and change : IJLC 8 (2015) 2, pp. 101-135

Persistent link: https://www.econbiz.de/10011539625

1
2
3
4
5
6
7
8
9
10
Next
Last